- 专利标题: Theramutein modulators
-
申请号: US17857478申请日: 2022-07-05
-
公开(公告)号: US11925647B2公开(公告)日: 2024-03-12
- 发明人: Gerard M. Housey
- 申请人: HMI Medical Innovations, LLC
- 申请人地址: US MI Southfield
- 专利权人: HMI Medical Innovations, LLC
- 当前专利权人: HMI Medical Innovations, LLC
- 当前专利权人地址: US MI Southfield
- 代理机构: Mueting Raasch Group
- 分案原申请号: US17038353 2020.09.30
- 主分类号: A61K31/5377
- IPC分类号: A61K31/5377 ; A61K31/166 ; A61K31/175 ; A61K31/195 ; A61K31/27 ; A61K31/415 ; A61K31/4196 ; A61K31/44 ; A61K31/4436 ; A61K31/444 ; A61K31/47 ; A61K31/4709 ; A61K31/495 ; A61K31/505 ; A61K31/506 ; A61K31/517 ; A61K31/53 ; C07C243/38 ; C07D213/77 ; C07D213/81 ; C07D213/86 ; C07D213/87 ; C07D215/38 ; C07D215/50 ; C07D231/14 ; C07D239/42 ; C07D239/48 ; C07D239/84 ; C07D253/065 ; C07D253/075 ; C07D401/12 ; C07D403/12 ; C07D405/12 ; C07D409/12 ; G01N33/50 ; G01N33/573 ; G01N33/574
摘要:
This invention relates to agents that are inhibitors or activators of variant forms of endogenous proteins and novel methods of identifying such variants. Of particular interest are inhibitors and activators of endogenous protein variants, encoded by genes which have mutated, which variants often arise or are at least first identified as having arisen following exposure to a chemical agent which is known to be an inhibitor or activator of the corresponding unmutated endogenous protein.
公开/授权文献
- US20220370469A1 THERAMUTEIN MODULATORS 公开/授权日:2022-11-24
信息查询
IPC分类: